CA2133995A1 - Methode et composition utilisees pour le traitement des affections comportant un deficit immunitaire - Google Patents

Methode et composition utilisees pour le traitement des affections comportant un deficit immunitaire

Info

Publication number
CA2133995A1
CA2133995A1 CA002133995A CA2133995A CA2133995A1 CA 2133995 A1 CA2133995 A1 CA 2133995A1 CA 002133995 A CA002133995 A CA 002133995A CA 2133995 A CA2133995 A CA 2133995A CA 2133995 A1 CA2133995 A1 CA 2133995A1
Authority
CA
Canada
Prior art keywords
treatment
composition
disorders involving
involving immunological
immunological dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002133995A
Other languages
English (en)
Other versions
CA2133995C (fr
Inventor
Ellis L. Kline
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Signal Coordinating Therapy Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US1993/003757 external-priority patent/WO1993020803A1/fr
Publication of CA2133995A1 publication Critical patent/CA2133995A1/fr
Application granted granted Critical
Publication of CA2133995C publication Critical patent/CA2133995C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07006—DNA-directed RNA polymerase (2.7.7.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002133995A 1992-04-22 1993-04-21 Methode et composition utilisees pour le traitement des affections comportant un deficit immunitaire Expired - Fee Related CA2133995C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87196892A 1992-04-22 1992-04-22
US07/871,968 1992-04-22
US4661193A 1993-04-19 1993-04-19
US08/046,611 1993-04-19
PCT/US1993/003757 WO1993020803A1 (fr) 1992-04-22 1993-04-21 Procede et composition pour le traitement de troubles associes a un dysfonctionnement immunologique

Publications (2)

Publication Number Publication Date
CA2133995A1 true CA2133995A1 (fr) 1993-10-28
CA2133995C CA2133995C (fr) 2007-07-24

Family

ID=27366937

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002133995A Expired - Fee Related CA2133995C (fr) 1992-04-22 1993-04-21 Methode et composition utilisees pour le traitement des affections comportant un deficit immunitaire

Country Status (1)

Country Link
CA (1) CA2133995C (fr)

Also Published As

Publication number Publication date
CA2133995C (fr) 2007-07-24

Similar Documents

Publication Publication Date Title
AU2160492A (en) Treatment of human diseases involving dysregulation or dysfunction of the nervous system
EP0612240A4 (fr) Procede servant a prolonger le temps de sejour vasculaire d'agents therapeutiques et diagnostiques particulaires.
AU4199489A (en) Composition for the treatment of erectile dysfunction
DE3584349D1 (de) Lhrh-analoga, welche die anti-lhrh-antikoerper stimulieren und diese enthaltende vakzine.
CA2141436A1 (fr) Traitement de la maladie d'alzheimer et modulation du systeme immunitaire par l'administration de delta-5-androstenes
WO1999064059A3 (fr) Utilisation de la secretine pour le traitement de l'autisme et d'autres troubles du comportement, troubles neurologiques ou immunologiques
KR100206481B1 (en) Galenic form for ocular administration and process for the preparation of same
AU2221688A (en) Method for stimulating the immune system
ZA871528B (en) The treatment of diseases of the immune system with diphenylhydantoin and its derivatives
AU6927087A (en) 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3- substituted-2-thioxo(or oxo)-5-pyrimidinecarboxylic acids and esters
EP0642333A4 (fr) Procede et composition pour le traitement de troubles associes a un dysfonctionnement immunologique.
AU628288B2 (en) Cancer-related antigen-specific human immunoglobulins and human/human hybridomas having the ability to produce said human immunoglobulins
AU4012893A (en) Method for inducing the acrosome reaction in human and animal spermatozoa
AU6494690A (en) Method for the prevention and treatment of bovine mastitis
EP0282343A3 (fr) Méthode pour stimuler la réponse immunitaire à des antigènes spécifiques
AU1439588A (en) Synergistic immunostimulating compositions and method
EP0273310A3 (fr) 5-Aryl-3H-1,2,4-triazol-3-ones et leur emploi comme anticonvulsifs
CA2133995A1 (fr) Methode et composition utilisees pour le traitement des affections comportant un deficit immunitaire
EP0273778A3 (fr) Comportement synergique de csf-1 et G-csf
EP0648124A4 (fr) Procede de stimulation du systeme immunitaire.
EP0579765A4 (en) Method and composition for the treatment of herpes related disorders
AU5381890A (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
AU2269392A (en) Method for treating immunological disorders and diseases
DE68915694D1 (de) Verfahren zur Herstellung von verzweigten 1,3-Glykolen und ihren Monoestern.
Zacharko The Charter of Rights and Freedoms: implications for education

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed